Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer. It works by reducing estrogen levels in the body, which can help slow or stop the growth of cancer cells. This medication is commonly prescribed for postmenopausal women.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery or other treatments to help prevent the cancer from returning. The medication works by inhibiting the enzyme aromatase, which is responsible for producing estrogen. By reducing estrogen levels, Femara can slow the growth of cancer cells that rely on this hormone.

Common effects of Femara may include hot flashes, joint pain, fatigue, and weakness. Some users may also experience hair thinning, sweating, and nausea. These effects can vary in severity and may not affect everyone who takes the medication.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. It is important to discuss any pre-existing conditions with a healthcare provider before starting this medication. Regular monitoring may be recommended to assess bone health and liver function.

Femara may interact with certain medications, including estrogen-containing therapies and some types of chemotherapy. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.